Anti hla-g specific antibodies

Inactive Publication Date: 2019-08-01
INVECTYS
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0041]FIG. 10. The 15E7 monoclonal antibody binds specifically to HLA-G and not to classical MHC class I molecules. These binding assays assessing the specificity of 15E7 were performed using lymphoma cell lines (LCL DES, LCL BRO and RPMI8866) expressing human classical MHC class I molecules at their surfa

Problems solved by technology

HLA-G immunization has been remarkably di

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti hla-g specific antibodies
  • Anti hla-g specific antibodies
  • Anti hla-g specific antibodies

Examples

Experimental program
Comparison scheme
Effect test

example 1

n of Anti-HLA-G Antibodies in Mice

[0267]Design of the Immunogen

[0268]The inventors designed a highly HLA-G specific peptide corresponding to the α3 amino acid region 189-203 of HLA-G, referenced as “Peptide Constrained: PC-1” (FIG. 1A; in bold and underlined), and used it to immunize mice.

[0269]PC-1 sequence: VTHHPVFDYEATLRC (SEQ ID NO: 56)

[0270]PC-1 immunogen is expected to generate therapy-suitable anti-HLA-G monoclonal antibodies specific for HLA-G α3-containing isoforms independently of β2M association.

[0271]Immunization, Hybridoma Generation and scFv Production

[0272]The immunization protocol using the PC-1 peptide coupled to KLH is described in Materials and Methods section. C57BL / 6 and BALB / c mice were used for peptide immunization.

[0273]Briefly, mice were intraperitoneally primed with PC-1-KLH conjugate in CFA and boosted with 4 IP in IFA. Sera from immunized mice were collected at different time points along the immunization procedure and were tested using Bioplex-HLA-G5, HL...

example 2

haracterization of the Mouse Monoclonal Antibody 15E7 and scFv R4C-C3

[0278]The cDNA sequences encoding the light and heavy chain variable regions of the monoclonal antibody 15E7 and the R4C-C3 scFv were obtained using standard PCR and DNA sequencing methods.

[0279]Monoclonal Antibody 15E7

[0280]The nucleotide and amino acid sequences of the light chain variable region of 15E7 are shown in FIG. 2A.

[0281]The nucleotide and amino acid sequences of the heavy chain variable region of 15E7 are shown in FIG. 3A.

[0282]The greatest variability in the light and heavy chains is located mainly within the hypervariable regions called Complementarity-Determining Regions (CDRs) which define the specificity of the antibody. Analysis of the 15E7 VL and VH sequences led to the CDR1, CDR2 and CDR3 regions delineation of the light and heavy chains respectively as shown in FIGS. 2A and 3A.

[0283]The sequence of the 15E7 κ light chain was compared to the known mouse germline immunoglobulin light chain seque...

example 3

ization of Anti-HLA-G Monoclonal Antibody 15E7

[0291]Protein Analysis

[0292]The 15E7 monoclonal antibody was analyzed by SDS-PAGE gel electrophoresis (FIG. 6A). The heavy chain molecular weight is around 50 kDa and light chain around 25 kDa. Having two copies of each, the molecular weight of 15E7 is estimated to 150 kDa confirming that the monoclonal antibody 15E7 belongs to the murine IgG 2a class.

[0293]Isotyping and Affinity Determination

[0294]The isotype of 15E7 was assessed by ELISA. 15E7 isotype was determined to be IgG2a. The affinity of 15E7 was assessed by the BLITZ technology as described in the Materials and Methods section. Representative data are shown in FIG. 6B. Various concentrations of the PC-1 peptide conjugated to BSA ranging from 5 to 600 nM were incubated with the 15E7 coupled to the biosensor chip. For each concentration, the association (ka) and dissociation (kd) rates were measured and used to calculate the affinity constant KD (ka / kd), evaluated here as 1.57 nM...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Lengthaaaaaaaaaa
Login to View More

Abstract

The present invention relates to antibodies, or antigen-binding fragments thereof, directed against human leukocyte antigen-G (HLA-G) protein and raised against an immunogenic peptide derived from the a3 domain of HLA-G protein. The invention further relates to the immunogenic peptide, and methods for producing said anti-HLA-G specific antibodies. A particular embodiment refers to the monoclonal antibody with the arbitrary designation 15E7 for which the sequence is provided. Also a anti-HLA-G single-chain antibody gene library was generated and six specific binders were identified from that library.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a U.S. National Phase of International Patent Application No. PCT / EP2017 / 063503, filed Jun. 2, 2017, which claims priority to EP Patent Application No. 16305650.0, filed on Jun. 3, 2016, all of which are herein incorporated by reference in their entirety.[0002]The present invention relates to antibodies, or antigen-binding fragments thereof, raised against an immunogenic peptide derived from the α3 domain of human leukocyte antigen G (HLA-G) protein.TECHNICAL BACKGROUND[0003]In cancer, one major immune escape mechanism is the expression of inhibitory molecules on the cell surface impairing T cell signaling. Many of these inhibitory molecules are considered as Immune Check Points (ICP) and refer to numerous inhibitory pathways first demonstrated to maintain self-tolerance and to modulate the duration and amplitude of physiological immune responses within peripheral tissues to avoid collateral tissue damages.[0004]HLA-G ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/28C07K7/08C07K7/50A61P35/00A61P31/12
CPCC07K16/2833C07K7/08C07K7/50A61P35/00A61P31/12C07K2317/92C07K2317/622C07K2317/33C07K2317/76C07K2317/34C07K7/64G01N33/56983G01N33/574G01N2333/70539A61K2039/505
InventorLANGLADE DEMOYEN, PIERREHUET, THIERRYCAUMARTIN, JULIENLOUSTAU, MARIAWEHBE, MARIA
OwnerINVECTYS